Baojin J. Wang
Zhengzhou, 450001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Comparative analysis for optimal LSD1 inhibitors evaluation techniques: pros and cons.
Journal: Journal of pharmaceutical analysis
Published: April 20, 2025
Cold atmospheric plasma drives USP49/HDAC3 axis mediated ferroptosis as a novel therapeutic strategy in endometrial cancer via reinforcing lactylation dependent p53 expression.
Journal: Journal of translational medicine
Published: January 13, 2025
MiR-675 Inhibits Primary Ovarian Tumor Growth and Metastasis by Suppressing EMT and TGFβ Signaling.
Journal: Journal of Cancer
Published: August 22, 2024
Application of optical coherence tomography in the evaluation of cervical lesions: a multicenter study
Journal: Zhonghua fu chan ke za zhi
Published: April 21, 2024
A biomimetic spore nanoplatform for boosting chemodynamic therapy and bacteria-mediated antitumor immunity for synergistic cancer treatment.
Journal: Asian journal of pharmaceutical sciences
Published: February 19, 2024
Efficacy and safety of oral ibrexafungerp in Chinese patients with vulvovaginal candidiasis: a phase III, randomized, double-blind study.
Journal: Infection
Published: January 25, 2024
Characteristics and utility of high-resolution optical coherence microscopy images of endocervical canal lesions.
Journal: American journal of clinical pathology
Published: September 20, 2023
Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.
Journal: Journal of translational medicine
Published: December 08, 2022
Study on the application of optical coherence microscopy in Hirschsprung's disease.
Journal: Scientific reports
Published: October 31, 2022
Cryptotanshinone inhibits ovarian tumor growth and metastasis by degrading c-Myc and attenuating the FAK signaling pathway.
Journal: Frontiers in cell and developmental biology
Published: June 01, 2022
Characterization of Kinesin Family Member 2C as a Proto-Oncogene in Cervical Cancer.
Journal: Frontiers in pharmacology
Published: September 29, 2021
Last Updated: 09/26/2026